These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

643 related items for PubMed ID: 32440914

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Adjuvant Chemoradiation After Surgical Resection in Elderly Patients With High-Risk Squamous Cell Carcinoma of the Head and Neck: A National Cancer Database Analysis.
    Woody NM, Ward MC, Koyfman SA, Reddy CA, Geiger J, Joshi N, Burkey B, Scharpf J, Lamarre E, Prendes B, Adelstein DJ.
    Int J Radiat Oncol Biol Phys; 2017 Jul 15; 98(4):784-792. PubMed ID: 28602410
    [Abstract] [Full Text] [Related]

  • 3. Machine Learning-Guided Adjuvant Treatment of Head and Neck Cancer.
    Howard FM, Kochanny S, Koshy M, Spiotto M, Pearson AT.
    JAMA Netw Open; 2020 Nov 02; 3(11):e2025881. PubMed ID: 33211108
    [Abstract] [Full Text] [Related]

  • 4. Survival benefit of post-operative chemotherapy for intermediate-risk advanced stage head and neck cancer differs with patient age.
    Chen MM, Colevas AD, Megwalu U, Divi V.
    Oral Oncol; 2018 Sep 02; 84():71-75. PubMed ID: 30115479
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Prognostic significance of basaloid squamous cell carcinoma in head and neck cancer.
    Linton OR, Moore MG, Brigance JS, Gordon CA, Summerlin DJ, McDonald MW.
    JAMA Otolaryngol Head Neck Surg; 2013 Dec 02; 139(12):1306-11. PubMed ID: 24158536
    [Abstract] [Full Text] [Related]

  • 8. Primary tumor volume is an important predictor of clinical outcomes among patients with locally advanced squamous cell cancer of the head and neck treated with definitive chemoradiotherapy.
    Strongin A, Yovino S, Taylor R, Wolf J, Cullen K, Zimrin A, Strome S, Regine W, Suntharalingam M.
    Int J Radiat Oncol Biol Phys; 2012 Apr 01; 82(5):1823-30. PubMed ID: 21549516
    [Abstract] [Full Text] [Related]

  • 9. Treatment sequence and survival in locoregionally advanced hypopharyngeal cancer: A surveillance, epidemiology, and end results-based study.
    Hochfelder CG, McGinn AP, Mehta V, Castellucci E, Kabarriti R, Ow TJ.
    Laryngoscope; 2020 Nov 01; 130(11):2611-2621. PubMed ID: 31821572
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Systematic review and individual patient data analysis of pediatric head and neck squamous cell carcinoma: An analysis of 217 cases.
    Bhanu Prasad V, Mallick S, Upadhyay AD, Rath GK.
    Int J Pediatr Otorhinolaryngol; 2017 Jan 01; 92():75-81. PubMed ID: 28012539
    [Abstract] [Full Text] [Related]

  • 13. Final Report of a Prospective Randomized Trial to Evaluate the Dose-Response Relationship for Postoperative Radiation Therapy and Pathologic Risk Groups in Patients With Head and Neck Cancer.
    Rosenthal DI, Mohamed ASR, Garden AS, Morrison WH, El-Naggar AK, Kamal M, Weber RS, Fuller CD, Peters LJ.
    Int J Radiat Oncol Biol Phys; 2017 Aug 01; 98(5):1002-1011. PubMed ID: 28721881
    [Abstract] [Full Text] [Related]

  • 14. Evaluating Adjuvant Therapy With Chemoradiation vs Radiation Alone for Patients With HPV-Negative N2a Head and Neck Cancer.
    Yan F, Li H, Kaczmar JM, Sharma AK, Day TA, Neskey DM, Pipkorn P, Zenga J, Graboyes EM.
    JAMA Otolaryngol Head Neck Surg; 2020 Dec 01; 146(12):1109-1119. PubMed ID: 32790830
    [Abstract] [Full Text] [Related]

  • 15. A phase 2 trial of surgery with perioperative INGN 201 (Ad5CMV-p53) gene therapy followed by chemoradiotherapy for advanced, resectable squamous cell carcinoma of the oral cavity, oropharynx, hypopharynx, and larynx: report of the Southwest Oncology Group.
    Yoo GH, Moon J, Leblanc M, Lonardo F, Urba S, Kim H, Hanna E, Tsue T, Valentino J, Ensley J, Wolf G.
    Arch Otolaryngol Head Neck Surg; 2009 Sep 01; 135(9):869-74. PubMed ID: 19770418
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Prospective Study of Cetuximab, Carboplatin, and Radiation Therapy for Patients With Locally Advanced Head and Neck Squamous Cell Cancer Unfit for Cisplatin.
    Corry J, Bressel M, Fua T, Herschtal A, Solomon B, Porceddu SV, Wratten C, Rischin D.
    Int J Radiat Oncol Biol Phys; 2017 Jul 15; 98(4):948-954. PubMed ID: 28483336
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Intra-arterial chemoradiation for T3-4 oral cavity cancer: treatment outcomes in comparison to oropharyngeal and hypopharyngeal carcinoma.
    Doweck I, Robbins KT, Samant S, Vieira F.
    World J Surg Oncol; 2008 Jan 14; 6():2. PubMed ID: 18194553
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 33.